Indrayani Biotech Ltd - 526445 - Intimation Of ISIN For Rights Entitlements Of Indrayani Biotech Limited
Indrayani Biotech announced the ISIN details for its partly paid-up Rights Issue. The issue, approved by the Right Issue Committee on April 9, 2026, involves shares with a face value of ₹10 and a paid-up value of ₹2.50.
Apr 21 2026 13:04:00
Indrayani Biotech Ltd - 526445 - Record Date For The Partly Paid-Up Rights Issue Has Been Fixed As 28Th April, 2026
Indrayani Biotech fixed April 28, 2026, as the Record Date for its Rights Issue. The company will offer 3.25 crore rights equity shares at ₹15 each, with an entitlement ratio of 5 rights shares for every 7 fully paid-up equity shares held.
Apr 09 2026 21:04:00
Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Raising of Funds
Indrayani Biotech's Rights Issue Committee approved terms for issuing 3.25 crore partly paid-up equity shares at ₹15 each, targeting a capital raise of up to ₹49.90 crore. The record date is set for April 28, 2026, with the issue opening on May 27, 2026, and closing on June 25, 2026.
Apr 09 2026 21:04:00
Indrayani Biotech Ltd - 526445 - Board Meeting Outcome for Outcome Of Board Meeting Held On 9Th April, 2026
Indrayani Biotech board approved exploring a preliminary proposal for demerging its food division into a separate company. A Restructuring Committee was constituted to oversee the evaluation and appoint various experts, including legal and financial advisors.
Apr 09 2026 18:04:00
Indrayani Biotech Ltd - 526445 - Regulation 30 - Clarification On Price Movement
Indrayani Biotech clarified recent share price movement, attributing it to ongoing discussions regarding a Rights Issue and a potential demerger of its food business. Meetings are scheduled for April 9, 2026, to address these matters.
Apr 09 2026 15:04:00
Indrayani Biotech Ltd - 526445 - Board Meeting Intimation for The Company Has Scheduled A Board Meeting On 9Th April, 2026
Indrayani Biotech's board will convene on April 9, 2026, to evaluate a demerger proposal. This strategic move aims to spin off a unit into a separate entity to enhance shareholder value.
Apr 06 2026 17:04:00
Read More